Summary: H.R.2112 — 111th Congress (2009-2010)All Information (Except Text)

There is one summary for H.R.2112. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (04/27/2009)

Lung Cancer Mortality Reduction Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services (the HHS Secretary) to implement the Lung Cancer Mortality Reduction Program to achieve a reduction of at least 25% in the mortality rate of lung cancer by 2015. Includes within such program: (1) a strategic review and prioritization of research grants; (2) an expansion of research programs, such as on predispositions to lung cancer; and (3) the expedited development of computer assisted diagnostic, surgical, treatment, and drug testing innovations.

Amends the Federal Food, Drug, and Cosmetic Act to apply provisions related to drugs for rare diseases or conditions to: (1) chemoprevention drugs for precancerous conditions of the lungs; (2) drugs for targeted therapeutic treatment of lung cancer; and (3) drugs to curtail or prevent nicotine addiction.

Requires the HHS Secretary to establish an early disease research and management program targeted at the high incidence and mortality rates of lung cancer among minority and low income populations.

Requires the Secretary of Defense (DOD) and the Secretary of Veterans Affairs (VA) to coordinate with the HHS Secretary in: (1) the development of the Lung Cancer Mortality Reduction Program; (2) the implementation of an early detection and disease management research program for military personnel and veterans whose smoking history and exposure to carcinogens during active duty service has increased their risk for lung cancer; and (3) the implementation of coordinated care programs for military personnel and veterans diagnosed with lung cancer.

Requires the HHS Secretary to convene a Lung Cancer Advisory Board to monitor the programs established under this Act.